Discovery, Development, and Invention of Small Molecules Against Microbial Infections
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Antimicrobial Agents and Resistance".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 135
Special Issue Editor
Interests: pharmaceutical sciences; health sciences; drug discovery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Microbial infections, caused by bacteria, viruses, fungi, and parasites, pose a significant global health threat, and the development of effective treatments is essential. This collection of articles explores various aspects of small molecule research in the fight against infections. It covers the discovery of inventive compounds (natural, semisynthetic, and synthetic) with antimicrobial properties, the development of these compounds into potential therapies, and innovative approaches (e.g., artificial intelligence, machine learning, deep learning, drug repurposing, molecular docking, network pharmacology, signature matching, genetic association, retrospective clinical analysis, pathway mapping, novel data sources, design and synthesis of antimicrobial agents, natural and herbal antimicrobial products, binding assays, understanding the mechanisms of action, new antimicrobial drug targets, phenotype screening, antimicrobial formulations and compositions, and biopharmaceutical studies) to tackling drug resistance. It is hoped that this Special Issue offers a comprehensive overview of the current state of inventive research and development in the field of small-molecule-based therapies against microbial infections, shedding light on promising avenues for addressing this critical global health concern.
Dr. Mohd Imran
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- artificial intelligence
- machine learning
- deep learning
- drug repurposing
- molecular docking
- network pharmacology
- signature matching
- genetic association
- retrospective clinical analysis
- pathway mapping
- novel data sources
- design and synthesis of antimicrobial agents
- natural and herbal antimicrobial products
- binding assays
- new antimicrobial drug targets
- phenotype screening
- antimicrobial formulations and compositions
- biopharmaceutical studies
